Managing MS

Certain chronic neurodegenerative disorders, such as Parkinson’s Disease, have been linked to the presence of an abnormal form of a protein called alpha-synuclein. Approximately 2.5 million patients in the US suffer from synucleinopathies. Synucleinopathies are progressive neurodegenerative diseases, each with different prognoses.  Many often take years to diagnose as the initial signs are subtle and […]

While the “feel good effect” has long been associated with the use of the monoclonal antibody Natalizumab, there is now evidence that the wearing-off of this and other monoclonal antibodies is associated with depression.  In fact, more than half of MS patients treated with the monoclonal antibodies Ocrevus, Rituxan, and Natalizumab who were surveyed reported

  That gym membership may pay off more than you know.  We have known for a long time that exercise and low-fat diets can reduce your cardiovascular risk and reduce the risk of strokes and heart attacks.  A recent study has now suggested that a healthy lifestyle, including exercise, minimal alcohol intake, not smoking, and

Patients with neurodegenerative disorders such as Multiple Sclerosis (MS) and Parkinson’s Disease (PD) may find hope in the most unlikely of resources: GOLD.  Researchers at the University of Texas Southwestern Medical Center have been testing the treatment of oral intake of gold nanocrystals in MS and PD patients suffering from problems in motor movement. MS

Primary care doctors are the first line of defense against all disease, charged with the responsibility of recognizing and diagnosing all disorders, including neurologic conditions.  In fact, due to the growing shortage of neurologists, primary care doctors currently care for approximately 75% of all neurologic patients.  Unfortunately, all evidence to date suggests that primary care